Amgen Follows BMS’s Lead With a US$1.5 B Collaboration With CytomX
By Natasha Piper
Pharma Deals Review: Vol 2017 Issue 10 (Table of Contents)
Published: 12 Oct-2017
DOI: 10.3833/pdr.v2017.i10.2279 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Amgen has signed a deal worth up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS